RecruitingNot ApplicableNCT06681818

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy


Sponsor

Englewood Hospital and Medical Center

Enrollment

125 participants

Start Date

Nov 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patient plans to have partial liver resection for primary liver pathology or metastatic disease
  • Patient is able to comprehend and willing to sign the written consent form

Exclusion Criteria2

  • Patients \< 18 years
  • Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test

Interventions

OTHERcarbon monoxide measurement via smokerlyzer

participants in this study will provide breath samples for carbon monoxide measurements pre and post liver resection


Locations(1)

Englewood Hospital

Englewood, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06681818


Related Trials